Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,602 across all filing types
Latest filing 2026-01-06 Share Issue/Capital Cha…
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it specifically details changes in share capital and issued shares, it falls under the category of share capital changes and reporting. Among the provided options, 'SHA' (Share Issue/Capital Change) is the most accurate classification for this type of regulatory disclosure.
2026-01-06 English
List of Directors and Their Role and Function
Regulatory Filings Classification · 1% confidence The document is a formal announcement from Sinopharm Group Co. Ltd. listing the current members of the Board of Directors and their respective roles and functions within various board committees. This type of disclosure is standard for corporate governance updates regarding board composition and committee structure. Since it specifically details the board and committee membership rather than announcing a change in personnel (MANG) or a specific governance report (CGR), it falls under the general regulatory filing category for corporate structure disclosures.
2025-12-19 English
ANNOUNCEMENT POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 19 DECEMBER 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement titled 'POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING'. It details the voting outcomes for specific resolutions proposed at the EGM held on December 19, 2025, including the number of votes for and against each resolution. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2025-12-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies to report monthly movements in securities, share capital, and treasury shares. Since it details changes in share capital and issued shares, it falls under the category of share capital changes/movements. Among the provided options, 'SHA' (Share Issue/Capital Change) is the most accurate classification for this type of regulatory disclosure regarding securities movements.
2025-12-04 English
FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, 19 DECEMBER 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Form of Proxy' for an Extraordinary General Meeting (EGM). It provides shareholders with the ability to appoint a proxy to vote on specific resolutions (appointment of directors) on their behalf. This falls under the category of Proxy Solicitation & Information Statement (PSI), as it is a standard document used to solicit votes and provide information for a shareholder meeting.
2025-12-03 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Extraordinary General Meeting' (EGM) issued by Sinopharm Group Co. Ltd. It outlines the agenda for an upcoming meeting, including resolutions for the appointment of directors, and provides instructions for shareholders regarding proxy voting, registration, and attendance. This document is a formal solicitation of shareholder action and information for an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-12-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.